Red Blood Cells from Individuals with Abdominal Obesity or Metabolic Abnormalities Exhibit Less Deformability upon Entering a Constriction
Nancy F Zeng, Jordan E Mancuso, Angela M Zivkovic, Jennifer T Smilowitz, William D Ristenpart, Nancy F Zeng, Jordan E Mancuso, Angela M Zivkovic, Jennifer T Smilowitz, William D Ristenpart
Abstract
Abdominal obesity and metabolic syndrome (MS) are multifactorial conditions associated with increased risk of cardiovascular disease and type II diabetes mellitus. Previous work has demonstrated that the hemorheological profile is altered in patients with abdominal obesity and MS, as evidenced for example by increased whole blood viscosity. To date, however, no studies have examined red blood cell (RBC) deformability of blood from individuals with obesity or metabolic abnormalities under typical physiological flow conditions. In this study, we pumped RBCs through a constriction in a microfluidic device and used high speed video to visualize and track the mechanical behavior of ~8,000 RBCs obtained from either healthy individuals (n = 5) or obese participants with metabolic abnormalities (OMA) (n = 4). We demonstrate that the OMA+ cells stretched on average about 25% less than the healthy controls. Furthermore, we examined the effects of ingesting a high-fat meal on RBC mechanical dynamics, and found that the postprandial period has only a weak effect on the stretching dynamics exhibited by OMA+ cells. The results suggest that chronic rigidification of RBCs plays a key role in the increased blood pressure and increased whole blood viscosity observed in OMA individuals and was independent of an acute response triggered by consumption of a high-fat meal.
Trial registration: ClinicalTrials.gov NCT01803633.
Conflict of interest statement
Competing Interests: The authors have declared that no competing interests exist.
Figures
References
- Grundy SM, Brewer HB Jr., Cleeman JI, Smith SC Jr., & Lenfant C. Definition of metabolic syndrome—Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc. Biol. 2004; 24(2):E13–E18.
- Eckel RH, Grundy SM, & Zimmet PZ. The metabolic syndrome. Lancet. 2005; 365(9468):1415–1428.
- Alberti K, Zimmet P, & Shaw J. The metabolic syndrome—a new worldwide definition. Lancet. 2005; 366(9491):1059–1062.
- Després J.-P., and Lemieux I. 2006. Abdominal obesity and metabolic syndrome. Nature 444; 881–887.
- Cleeman JI, Grundy SM, Becker D, Clark LT, Cooper RS, Denke MA et al. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001; 285(19):2486–2497.
- Ng M, Fleming T, Robinson M., Thomson B, Graetz N, Margono C, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014; 6736: 1–16.
- Grundy SM, Cleeman JI, Daniels SR., Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome Executive Summary. Curr. Opin. Cardiol. 2006; 21: 1–6.
- Ervin RB Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003–2006. Natl. Health Stat. Report. 2009; 1–7.
- Isomaa B, Almgren P, Tuomi T, Forsen B, Laht K, Nissen M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001; 24(4):683–689.
- Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers V. K, et al. Metabolic syndrome and risk of incident cardiovascular events and death—A systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol. 2007; 49(4):403–414.
- Perez-Martinez P, Alcala-Diaz JF, Delgado-Lista J, Garcia-Rios A, Gomez-Delgado F, Marin-Hinojosa C, et al. Metabolic phenotypes of obesity influence triglyceride and inflammation homoeostasis. European journal of clinical investigation. 2014;44(11):1053–64. 10.1111/eci.12339
- Caimi G, Sinagra D, Scarpitta AM, & Lo Presti R. Plasma viscosity and insulin resistance in metabolic syndrome. Int J Obes. 2001; 25(12):1856–1857.
- Lo Presti R, Singara D, Montana M, Scarpitta AM, Cantania A, & Caimi G. Haemorheological profile in metabolic syndrome. Clin Hemorheol Micro. 2002; 26(4):241–247.
- Brun JF, Aloulou I, & Varlet-Marie E. Hemorheological aspects of the metabolic syndrome: markers of insulin resistance, obesity or hyperinsulinemia? Clin Hemorheol Micro. 2004; 30(3–4):203–209.
- Toker S, Rogowski O, Melamed S, Shirom A, Shapira I, Berliner S, et al. Association of components of the metabolic syndrome with the appearance of aggregated red blood cells in the peripheral blood. An unfavorable hemorheological finding. Diabetes Metab Rev. 2005; 21(2):197–202.
- Aloulou I, Varlet-Marie E, Mercier J, & Brun J-F. Hemorheological disturbances correlate with the lipid profile but not with the NCEP-ATPIII score of the metabolic syndrome. Clin Hemorheol Micro. 2006; 35(1–2):207–212.
- Zhang L, Pu K, Zhang S-Y, & Ren W-Q. Blood rheological properties are strongly related to the metabolic syndrome in middle-aged Chinese. Int J Cardiol. 2006; 112(2):229–233.
- Irace C, Scavelli F, Carallo C, Serra R, & Gnasso A. Plasma and blood viscosity in metabolic syndrome. NMCD. 2006; 19(7):476–480.
- Vaya A, Hernandez-Mijares A, Bonet E, Sendra R, Sola E, Perez R, et al. Association between hemorheological alterations and metabolic syndrome. Clin Hemorheol Micro. 2011; 49(1–4):493–503.
- Ageno W, Dentali F, & Grandi AM. New evidence on the potential role of the metabolic syndrome as a risk factor for venous thromboembolism. J Thromb Haemost. 2009; 7(5):736–738. 10.1111/j.1538-7836.2009.03327.x
- Helal O, Defoort C, Robert S, Marin C, Lesavre N, Lopez-Miranda J, et al. Increased levels of microparticles originating from endothelial cells, platelets and erythrocytes in subjects with metabolic syndrome: relationship with oxidative stress. NMCD. 2011; 21(9):665–671. 10.1016/j.numecd.2010.01.004
- Wiernsperger N, Nivoit P, De Aguiar LG, & Bouskela E. Microcirculation and the metabolic syndrome. Microcirculation. 2007; 14(4–5):403–438.
- Gyawali P, Richards RS, Nwose EU, & Bwititi PT. Whole-blood viscosity and metabolic syndrome. Clin Lipidol. 2012; 7(6):709–719.
- Marossy A, Svorc P, Kron I, & Gresova S. Hemorheology and Circulation. Clin Hemorheol Micro. 2009; 42(4):239–258.
- Wan J, Ristenpart WD, & Stone HA. Dynamics of shear-induced ATP release from red blood cells. PNAS. 2008; 105(43):16432–16437. 10.1073/pnas.0805779105
- Forsyth AM, Wan J, Ristenpart WD, & Stone HA. The dynamic behavior of chemically "stiffened" red blood cells in microchannel flows. Microvasc Res. 2010; 80(1):37–43. 10.1016/j.mvr.2010.03.008
- Zeng NF, & Ristenpart WD. Mechanical response of red blood cells entering a constriction. Biomicrofluidics. 2014; 8(6): 064123: 1–17.
- Zhao R, Antaki J, Naik T, Bachman T, Kameneva M, & Wu Z. Microscopic investigation of erythrocyte deformation dynamics. Biorheology. 2006; 43:747–765
- Yaginuma T, Oliveira MSN, Lima R, Ishikawa T, & Yamaguchi T. Human red blood cell behavior under homogeneous extensional flow in a hyperbolic-shaped microchannel. Biomicrofluidics. 2013; 7(5):054110.
- Lee SS, Yim Y, Ahn KH, & Lee SJ. Extensional flow-based assessment of red blood cell deformability using hyperbolic converging microchannel. Biomedical Microdevices. 2009; 11(5):1021–1027. 10.1007/s10544-009-9319-3
- Faustino V, Pinho D, Yaginuma T, Calhelha R, Ferreira I CFR, & Lima R. Extensional flow-based microfluidic device: deformability assessment of red blood cells in contact with tumor cells. BioChip Journal. 2014; 8(1):42–57.
- Rodrigues RO, Pinho D, Faustino V, & Lima R. A simple microfluidic device for the deformability assessment of red blood cells in continuous flow. Biomedical Microdevices. 2015; 17(6): 108 10.1007/s10544-015-0014-2
- Demmer E, Van Loan MD, Rivera N, Rogers TS, Gertz ER, German JB, et al. Consumption of a high-fat meal containing cheese compared with a vegan alternative lowers postprandial C-reactive protein in overweight and obese individuals with metabolic abnormalities: a randomised controlled cross-over study. Journal of Nutritional Science 2016, 5.
- Ascaso JF, Pardo S, Real JT, Lorente RI, Priego A, & Carmena R. Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Diabetes Care. 2003;26(12):3320–5.
- Thomas A. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the centers for disease control and prevention and the american heart association. Circulation. 2003;107:499
- Price AK, Fischer DJ, Martin RS, & Spence DM. Deformation-induced release of ATP from erythrocytes in a poly(dimethylsiloxane)-based microchip with channels that mimic resistance vessels. Anal Chem. 2004; 76(16):4849–4855.
- Uyuklu M, Cenqiz M, Ulker P, Hever T, Tripette J, Connes P, et al. Effects of storage duration and temperature of human blood on red cell deformability and aggregation. Clin Hemorheol. Micro. 2009; 41(4):269–278.
- Tangelder G. J., Slaaf D. W., Arts T., & Reneman R. S.. Wall shear rate in arterioles in-vivo least estimates from platelet velocity profiles. Am. J. Physiol. 1988. 254(6):H1059–H1064.
Source: PubMed